Correction to: Biomark Res (2019) 7:19
https://doi.org/10.1186/s40364-019-0170-2
The original article [1] contains an error in the legend of Fig. 1 whereby it is incorrectly stated that MEC stands for ‘mitoxantrone, etoposide, cyclophosphamide’.
It should instead be stated that MEC stands for ‘mitoxantrone, etoposide, cytarabine’.
Contributor Information
Yongping Song, Email: songyongping@163.com.
Delong Liu, Email: DELONG_LIU@NYMC.EDU.
Reference
- 1.Zhao J, Song Y, Liu D. Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia. Biomarker Research. 2019;7:19. doi: 10.1186/s40364-019-0170-2. [DOI] [PMC free article] [PubMed] [Google Scholar]